PRCT
Procept Biorobotics Corp
NASDAQ · Health Care
$28.74
+1.34 (+4.89%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 240.66M | 128.87M | 495.16M | 489.54M | 398.61M |
| Net Income | -97,994,284 | -47,226,160 | 61.43M | 65.46M | 56.37M |
| EPS | — | — | — | — | — |
| Profit Margin | -40.7% | -38.7% | 12.4% | 13.4% | 14.1% |
| Rev Growth | +86.8% | +86.8% | -3.8% | +4.3% | +1.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 91.12M | 91.12M | 338.04M | 334.28M | 288.62M |
| Total Equity | 711.86M | 711.86M | 1.02B | 1.05B | 1.04B |
| D/E Ratio | 0.13 | 0.13 | 0.33 | 0.32 | 0.28 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -97,960,757 | -49,832,781 | 104.01M | 92.84M | 77.63M |
| Free Cash Flow | — | — | 68.04M | 76.16M | 45.47M |